Biotech juggernaut : hope, hype, and hidden agendas of entrepreneurial bioscience /
| Main Authors: | , |
|---|---|
| Corporate Author: | |
| Format: | eBook |
| Language: | English |
| Published: |
New York :
Routledge,
2019.
|
| Subjects: | |
| Online Access: | Connect to the full text of this electronic book |
Table of Contents:
- Cover; Half Title; Title Page; Copyright Page; Dedication; Table of Contents; Acknowledgments; Prologue: A Shared Encounter; References; Chapter 1: Introduction: The Biotech Juggernaut; The Rise of the Biotech Industry; Ethics, Dissent, and the Dream of Responsible Science; The Specter of Eugenics; Technological Pragmatism Replaces Moral Concern; The Jesse Gelsinger Story: The Human Cost of Hyped Technology; The Return of Gene Therapy; The Rise of Entrepreneurial Biology: Diamond v. Chakrabarty and the Bayh-Dole Act; Commerce Eclipsing Criticism; What Is to Come (in this Book?
- In the Future?)Notes; Sources Consulted for Chapter 1; Chapter 2: The Dawn of GM Humans; The Gene Bubble; The New Developmental Biology and Dreams of a Scientific Eugenics; Human Modification
- for Better or Worse; Sources Consulted for Chapter 2; Chapter 3: California Cloning: The Campaign; Clouding Issues at the Origin of CIRM; Enter California; Notes; Sources Consulted for Chapter 3; Chapter 4: California Cloning: The Aftermath; Conflicts of Interest in the Running of CIRM; The Egg Wars; Notes; Sources Consulted for Chapter 4; Chapter 5: Synthetic Biology: Extreme Genetic Engineering
- The Politics of Synthetic BiologyCoda; Notes; Sources Used for Chapter 5; Chapter 6: The Road to Gattaca; Paving the Road to Gattaca; Signposts Ignored: The Fallacy of Genetic Determinism; Misdirecting Signposts on the Road to Gattaca; Avoiding Gattaca?; Notes; Sources Consulted for Chapter 6; Chapter 7: Concluding Reflections; Sources Used for Chapter 7; Appendices; Appendix A: Position Paper on Human Germ Line Manipulation; Appendix B: Memo to CIRM Standards Working Group Challenging CIRM's 2013 Move to Change Egg Donation Reimbursement Policy
- Appendix C: Testimony by Sindy Wei, MD to the California Senate Health Committee re AB 926Appendix D: Testimony by Jennifer Schneider, MD to the California Senate Health Committee re AB 926; Appendix E: Testimony of Raquel Cool, Co-Founder, We Are Egg Donors, in Opposition To AB 2531; Appendix F: Email to SFSU Faculty from UCSF Center for Reproductive Health, September 21, 2017; Appendix G: Open Letter to President's Bioethics Commission from Fifty-Eight Civil Society Groups, December 16, 2010; Appendix H: Civil Society Letter to East Bay City Councils, 2011
- Appendix I: List of Civil Society Organizations Concerning Emerging BiotechnologiesGlossary; List of Abbreviations and Terms; Index